Corflow is a company headquartered in France. Brouky records 1 investor associated with the company.
Corflow is a medical device company developing a novel solution for the treatment of coronary artery disease. Their technology aims to improve blood flow to the heart muscle by removing plaque and restoring vessel patency.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.